Learn how to get Free YouTube subscribers, views and likes
Interpreting the Data with Tirzepatide
In an interview with CMHC cochair Dr. Anne Peters, Juan Frías, MD, shared his thoughts about the data with tirzepatide across key phase 3 trials, and the potential role of this agent in the management of patients with type 2 diabetes, as well as in the management of obesity (recorded October 21, 2022).
Recommended
